Device Patient Management Solutions

Paceart System Ecg Module

Payments companies reported to CMS as associated with Paceart System Ecg Module. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,020associated payments (2023-2025)
55clinicians with associated payments
1company reporting

By year

2023 $3,963
2024 $38.41
2025 $19.35

Payments reported as associated with Paceart System Ecg Module, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $1,655
Cardiovascular Disease $695
Internal Medicine $530
Thoracic Surgery (Cardiothoracic Vascular Surgery) $281
Nurse Practitioner $252
Interventional Cardiology $208

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Paceart System Ecg Module

These are the largest totals companies reported as associated with Paceart System Ecg Module. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Gerardo Aguirre Atlantis, FL Internal Medicine $306.05
Matthew Mckillop Jacksonville, FL Clinical Cardiac Electrophysiology $240.48
Jonathan Nieves Plantation, FL Anesthesiology $168.81
Raul Weiss Miami Beach, FL Clinical Cardiac Electrophysiology $160.66
Jose Torres Miami Beach, FL Cardiovascular Disease $160.66
Steven Schnur North Bay Village, FL Cardiovascular Disease $158.96
Glenn Dym Winter Park, FL Clinical Cardiac Electrophysiology $143.16
Oliver Horne Macon, GA Clinical Cardiac Electrophysiology $136.62
Venkata Sagi Jacksonville, FL Clinical Cardiac Electrophysiology $130.61
Usman Siddiqui Winter Park, FL Clinical Cardiac Electrophysiology $130.06

Prescribed Paceart System Ecg Module?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.